ATS Stat

HomeATS Stat ▶ Stat Sept. 20, 2021
Stat Sept. 20, 2021

Nominate a Colleague for the ATS 2022 Respiratory Health Awards

The ATS is now accepting nominations for 2022 respiratory health awards. Nominate a colleague who has demonstrated a commitment to respiratory health through their dedicated work, and outstanding contributions to the field, for one of the ATS 2022 Respiratory Health Awards:

 

Deadline: Oct. 22, 2021
Nominate a colleague today!

 

Time to Submit Your Abstracts for ATS 2022!

The ATS 2022 International Conference is headed to San Francisco! Join us, and submit your abstracts reporting on basic, translational, and clinical science research; epidemiologic, social, biobehavioral, and psychosocial investigations; or educational and quality improvement projects.

If you would like guidance as you begin the submission process, please see our resources:

View the full submission criteria, and begin yours today!
Deadline: Nov. 3,

 

Upcoming Events

Industry Innovation, “Evidence for Using a Biologic to Treat Two Different Eosinophil-Driven Diseases: Severe Eosinophilic Asthma and Chronic Rhinosinusitis with Nasal Polyps”

This program will review safety and efficacy data supporting the use of a biologic as a treatment for patients with severe eosinophilic asthma.

When: 6:30 p.m. ET, today, Sept. 29, 2021
Register now!

This program is sponsored by GlaxoSmithKline. 

 

ATS Clinical Practice Guidelines, Webinar Series: Pulmonary Infections

Join us to discusswhat is new or different according to three recently published clinical practice guidelines:

  1. Diagnosis and Treatment of Adults with Community-acquired Pneumonia: An Official ATS/IDSA Guideline (2019)
  2. Treatment of Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline (2019)
  3. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline (2020)

When: 6 p.m. ET, Sept. 30, 2021
Register now!

 

Industry Innovations, "Understanding Chronic Cough: Patient Presentation and Assessment"

Sidney S. Braman, MD, discusses presentation of chronic cough in patients, and reviews clinical management guidelines as well as potential mechanisms of chronic cough
.
When: 12 p.m. ET, Oct 4, 2021
Register now! to link tohttps://webinars.on24.com/merck/understandingchroniccough

  • Webinar sponsored by Merck
  • Intended for Health Care Professionals of the United States, its territories, and Puerto Rico
  • This is a non-CME event and consistent with FDA Guidelines

 

COVID-19 Critical Care Training Forum, “Delta in Children - What Are the Risks”
When: 8 p.m. ET, Oct. 5, 2021
Register now!

 

CME Opportunity! Emerging Treatment Strategies for the Management of Patients with Chronic Cough – Cases

In this second component of a two-part educational curriculum, pulmonary experts will discuss the prevalence, unmet clinical needs, and impact of chronic cough in patients who do not find relief from recommended management strategies. Full CME information available here!

When: 2 p.m. ET, Oct. 9, 2021
Register now!

Supported by an educational grant from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.

 

ATS Recognizes World Lung Day

On World Lung Day (WLD), members of the Forum of International Respiratory Societies (FIRS) and WLD partner organizations, such as the American Thoracic Society,  called for respiratory health to be a top priority in global decision-making beyond the COVID-19 pandemic.

According to the Global Impact of Respiratory Disease report, launched on Sept. 25, despite cost-effective health interventions being available, respiratory diseases remain a leading cause of death and disability. Nearly 200 million people, or 4 percent of the world’s population, have COPD and 3.2 million die of it each year, making it the third-leading cause of death worldwide. Read more!

 

Last Call! ATS 2022 Core Curriculum Faculty Speakers

Since 2012, the American Thoracic Society’s Core Curriculum has provided ATS members the opportunity to participate in relevant clinical reviews while fulfilling Maintenance of Certification requirements. The Core consists of a presentation at the ATS International Conference, contribution to an enduring maintenance of certification question module, and a potential scholarly product in the pillars of adult pulmonary, critical care, sleep, and pediatric pulmonary medicine. 

Please submit nominations via the speaker nomination form on the ATS website. For more information, please contact core@thoracic.org.

Deadline: Sept. 30, 2021